Nanotechnology-donated ischemic stroke therapeutics: evolving strategies from the basic to the cutting-edge
{{output}}
Ischemic stroke (IS) is accompanied by high disability and mortality. Thrombolysis and neuroprotection are the predominant therapeutic strategies for IS. However, thrombolytic drugs commonly suffer from hemorrhagic risks and unsatisfactory thrombus-targeting d... ...
